Impact of genetic variants of apolipoprotein e on lipid profile in patients with parkinson's disease

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Gregório, Michele L ^a   Pinhel, Marcela A S ^a   Sado, Caroline L ^b   Longo, Gabriela S ^c   Oliveira, Fábio N ^c   Amorim, Gisele S ^a   Nakazone, Marcelo A ^a   Florim, Greiciane M ^a   Mazeti, Camila M ^a   Martins, Denise P ^a   Tognola, Waldir A ^a   Brandão, Antonio C ^a   Júnior, Sidney Pinheiro ^a   De Godoy, Moacir F ^c   Souza, Dorotéia R S ^b  

^a FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c HOSPITAL DE BASE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ALLELE; ARTICLE; BRADYKINESIA; CHOLESTEROL BLOOD LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; ONSET AGE; PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RIGIDITY; TREMOR; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CONTROLLED CLINICAL TRIAL; GENETIC PREDISPOSITION; GENETICS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CHOLESTEROL, LDL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; PARKINSON DISEASE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 84885664710     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/641515     Document Type: Article

References (58)

1. Federoff M., Jimenez-Rolando B., Nalls M. A., Singleton A. B., A large study reveals no association between APOE and Parkinson's disease. Neurobiology of Disease 2012 46 2 389 392 2-s2.0-84859490620 10.1016/j.nbd.2012.02.002
2. Jankovic J., Parkinson's disease: clinical features and diagnosis. Journal of Neurology, Neurosurgery and Psychiatry 2008 79 4 368 376 2-s2.0-41149163183 10.1136/jnnp.2007.131045 (Pubitemid 351441488)
3. Shulman J. M., de Jager P. L., Feany M. B., Parkinson's disease: genetics and pathogenesis. Annual Review of Pathology 2011 6 193 222 2-s2.0-79751509762 10.1146/annurev-pathol-011110-130242
4. Alberio T., Bucci E. M., Natale M., Parkinson's disease plasma biomarkers: an automated literature analysis followed by experimental validation. Journal of Proteomics 2013 4 13 S1874 S3919
5. DATASUS-sistema Único de saúde 2010. 2010, http://portal.saude.gov.br/portal/arquivos/pdf/pcdt-doenca-parkinson-livro-2010. pdf
6. Ischiropoulos H., Beckman J. S., Oxidative stress and nitration in neurodegeneration: cause, effect, or association? The Journal of Clinical Investigation 2003 111 2 163 169 2-s2.0-0037237927 10.1172/JCI200317638 (Pubitemid 36105911)
7. Pimentel M. M. G., Moura K. C., Abdalla C. B., A study of LRRK2 mutations and Parkinson's disease in Brazil. Neuroscience Letters 2008 443 1 17 21 10.1016/j.neulet.2007.12.033
8. Maral Mouradian M., Recent advances in the genetics and pathogenesis of Parkinson disease. Neurology 2002 58 2 179 185 2-s2.0-0037154184 (Pubitemid 34084205)
9. Davignon J., Gregg R. E., Sing C. F., Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988 8 1 1 21 2-s2.0-0023860891 (Pubitemid 18049171)
10. Corbo R. M., Scacchp R., Apolipoprotein E (APOE) allele distribution in the world. Is APOE-4 a 'thrifty' allele? Annals of Human Genetics 1999 63 4 301 310 2-s2.0-0033398004 10.1017/S0003480099007575 (Pubitemid 30021229)
11. Beisiegel U., Weber W., Ihrke G., Herz J., Stanley K. K., The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature 1989 341 6238 162 164 2-s2.0-0024449363 (Pubitemid 19222781)
12. Bennet A. M., di Angelantonio E., Ye Z., Wensley F., Dahlin A., Ahlbom A., Keavney B., Collins R., Wiman B., de Faire U., Danesh J., Association of apolipoprotein e genotypes with lipid levels and coronary risk. Journal of the American Medical Association 2007 298 11 1300 1311 2-s2.0-34548736492 10.1001/jama.298.11.1300 (Pubitemid 47443344)
13. Souza D. R. S., de Godoy M. R., Hotta J., Tajara E. H., Brandão A. C., Pinheiro Júnior S., Tognola W. A., Dos Santos J. E., Association of apolipoprotein E polymorphism in late-onset Alzheimer's disease and vascular dementia in Brazilians. Brazilian Journal of Medical and Biological Research 2003 36 7 919 923 2-s2.0-0042092055 (Pubitemid 36939915)
14. Pinhel M. A. S., Nakazone M. A., Cação J. C., Piteri R. C. O., Dantas R. T., Godoy M. F., Godoy M. R. P., Tognola W. A., Conforti-Froes N. D. T., Souza D. R. S., Glutathione S-transferase variants increase susceptibility for late-onset Alzheimer's disease: association study and relationship with apolipoprotein E ε 4 allele. Clinical Chemistry and Laboratory Medicine 2008 46 4 439 445 2-s2.0-44949130928 10.1515/CCLM.2008.102 (Pubitemid 351820359)
15. Li Y. J., Hauser M. A., Scott W. K., Martin E. R., Booze M. W., Qin X. J., Walter J. W., Nance M. A., Hubble J. P., Koller W. C., Pahwa R., Stern M. B., Hiner B. C., Jankovic J., Goetz C. G., Small G. W., Mastaglia F., Haines J. L., Pericak-Vance M. A., Vance J. M., Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology 2004 62 11 2005 2009 2-s2.0-2942562810 (Pubitemid 38738212)
16. Pulkes T., Papsing C., Mahasirimongkol S., Busabaratana M., Kulkantrakorn K., Tiamkao S., Association between apolipoprotein E genotypes and Parkinson's disease. Journal of Clinical Neuroscience 2011 18 10 1333 1335 2-s2.0-80052097794 10.1016/j.jocn.2011.01.028
17. Smit M., van der Kooij-Meijs E., Frantz R. R., Havekes L., Klasen E. C., Apolipoprotein gene cluster on chromosome 19. Definite localization of the APOC2 gene and the polymorphic Hpa I site associated with type III hyperlipoproteinemia. Human Genetics 1988 78 1 90 93 2-s2.0-0023830163 (Pubitemid 18039534)
18. Huang X., Chen P. C., Poole C., APOE- ε 2 allele associated with higher pevalence of sporadic Parkinson disease. Neurology 2004 62 12 2198 2202 2-s2.0-2942711631 (Pubitemid 38787775)
19. Mahley R. W., Rall S. C. Jr., Apolipoprotein E: far more than a lipid transport protein. Annual Review of Genomics and Human Genetics 2000 1 1 507 537 2-s2.0-0034575124 10.1146/annurev.genom.1.1.507
20. The French Parkinson's Disease Genetics Study Group, Apolipoprotein E genotype in familial Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 1997 63 3 394 395 10.1136/jnnp.63.3.394
21. Harhangi B. S., de Rijk M. C., van Duijn C. M., van Broeckhoven C., Hofman A., Breteler M. M. B., APOE and the risk of PD with or without dementia in a population-based study. Neurology 2000 54 6 1272 1276 2-s2.0-0034724267 (Pubitemid 30174046)
22. Arai H., Maramatsu T., Higuchi S., Sasaki H., Trojanowski J. Q., Apolipoprotein E gene in Parkinson's disease with or without dementia. The Lancet 1994 344 8926 889 2-s2.0-0028061183 10.1016/S0140-6736(94)92862-2 (Pubitemid 24290400)
23. Huang X., Chen P., Kaufer D. I., Tröster A. I., Poole C., Apolipoprotein E and dementia in Parkinson disease: a meta-analysis. Archives of Neurology 2006 63 2 189 193 2-s2.0-32944462422 10.1001/archneur.63.2.189 (Pubitemid 43261729)
24. Bales K. R., Dodart J. C., DeMattos R. B., Holtzman D. M., Paul S. M., Apolipoprotein E, amyloid, and Alzheimer disease. Molecular Interventions 2002 2 6 363 339 2-s2.0-0345072821
25. Dallongeville J., Lussier-Cacan S., Davignon J., Modulation of plasma triglyceride levels by apoE phenotype: a meta- analysis. Journal of Lipid Research 1992 33 4 447 454 2-s2.0-0026514988
26. Buchanan D. D., Silburn P. A., Prince J. A., Mellick G. D., Association of APOE with Parkinson disease age-at-onset in women. Neuroscience Letters 2007 411 3 185 188 2-s2.0-34748903283 10.1016/j.neulet.2006.07.080 (Pubitemid 44828271)
27. Ezquerra M., Campdelacreu J., Gaig C., Compta Y., Muñoz E., Martí M. J., Valldeoriola F., Tolosa E., Lack of association of APOE and tau polymorphisms with dementia in Parkinson's disease. Neuroscience Letters 2008 448 1 20 23 2-s2.0-55749096543 10.1016/j.neulet.2008.10.018
28. Gallegos-Arreola M. P., Figuera L. E., Ortiz G. G., Jiménez-Gil F. J., Ramírez-Vega J., Ruíz-Sandoval J. L., Puebla-Pérez A. M., Troyo-Sanroman R., García-Ortiz J. E., Sanchez-Corona J., Zúñiga-González G. M., Apolipoprotein e genotypes in Mexican patients with Parkinson's disease. Disease Markers 2009 27 5 225 230 2-s2.0-77249107568 10.3233/DMA-2009-0667
29. Kurz M. W., Dekomien G., Nilsen O. B., Larsen J. P., Aarsland D., Alves G., APOE alleles in parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study. Journal of Geriatric Psychiatry and Neurology 2009 22 3 166 170 2-s2.0-70349682442 10.1177/0891988709332945
30. López M., Guerrero J., Yescas P., Boll M.-C., Familiar I., Ochoa A., Rasmussen A., Alonso M. E., Apolipoprotein E ε 4 allele is associated with Parkinson disease risk in a Mexican Mestizo population. Movement Disorders 2007 22 3 417 420 2-s2.0-34147150135 10.1002/mds.21340 (Pubitemid 46569703)
31. Martinez M., Brice A., Vaughan J. R., Zimprich A., Breteler M. M. B., Meco G., Filla A., Farrer M. J., Bétard C., Singleton A., Hardy J., de Michele G., Bonifati V., Oostra B. A., Gasser T., Wood N. W., Dürr A., Agid Y., Bonnet A.-M., Borg M., Broussolle E., Damier P., Destée A., Durif F., Feingold J., Fénelon G., Lohmann E., Penet C., Pollak P., Rascol O., Tison F., Tranchant C., Vérin M., Viallet F., Vidailhet M., Warter J. M., Nicholl D., Müller-Myhsok B., Harhangi S., Fabrizio E., Vanacore N., Volpe G., Apolipoprotein E4 is probably responsible for the chromosome 19 linkage peak for Parkinson's disease. American Journal of Medical Genetics B 2005 136 1 72 74 2-s2.0-21444443619 10.1002/ajmg.b.30196 (Pubitemid 40917532)
32. Pankratz N., Byder L., Halter C., Rudolph A., Shults C. W., Conneally P. M., Foroud T., Nichols W. C., Lyons K., Marder K., Marshall F., Oakes D., Rudolph A., Shinaman A., Siemers E., Wojcieszek J., Belden J., Carter J., Camicioli R., Andrews P., Panisset M., Hall J., Hubble J., Fernandez M., Reider C., Rajput A., Rajput A., Shirley T., Mendis T., Grimes D. A., Gray P., Ramos C. S., Roque S., Pfeiffer R., Pfeiffer B., Elmer L., Davis K., Friedman J., Fernandez H., Lannon M., Reich S., Dunlop B., Seeberger L., O'Brien C., Judd D., Hauser R., Zesiewicz T., Delgado H., Fontaine D., Jennings D., Marek K., Mendick S., Aminoff M., DiMinno M., Lewitt P., de Angelis M., Pahwa R., Thomas S., Truong D., Pathak M., Tran A., Rodnitzky R., Dobson J., Koller W., Weiner W., Lyons K., Kurlan R., Berry D., Bertoni J., Peterson C., Martin W., Wieler M., Tuite P., Schacherer R., Harris J., Jankovic J., Hunter C., Lang A., Kleimer-Fisman G., Nieves A., So J., Factor S., Evans S., Manyam B., Wulbrecht B., Walker F., Hunt V., Gordon M. F., Hamman J., Kang U. J., Young J., Blindauer K., Petit J., Rao J., Cook M., Stacy M., Williamson K., Pullman R. S., Boyar K., Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia. Movement Disorders 2006 21 1 45 49 2-s2.0-33244482562 10.1002/mds.20663 (Pubitemid 43273748)
33. Ryu H. G., Kwon O. D., Apolipoprotein E epsilon 4 allele is not associated with age at onset or MMSE of Parkinson's disease in a Korean study. Parkinsonism and Related Disorders 2010 16 9 615 617 2-s2.0-77958152870 10.1016/j.parkreldis.2010.06.015
34. Vefring H., Haugarvoll K., Tysnes O.-B., Larsen J. P., Kurz M. W., The role of APOE alleles in incident Parkinson's disease. The Norwegian ParkWest Study. Acta Neurologica Scandinavica 2010 122 6 438 441 2-s2.0-77958519017 10.1111/j.1600-0404.2010.01362.x
35. Hu G., Antikainen R., Jousilahti P., Kivipelto M., Tuomilehto J., Total cholesterol and the risk of Parkinson disease. Neurology 2008 70 21 1972 1979 2-s2.0-44949137294 10.1212/01.wnl.0000312511.62699.a8
36. Sohmiya M., Tanaka M., Wei Tak N., Yanagisawa M., Tanino Y., Suzuki Y., Okamoto K., Yamamoto Y., Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease. Journal of the Neurological Sciences 2004 223 2 161 166 2-s2.0-4444278377 10.1016/j.jns.2004.05.007 (Pubitemid 39164358)
37. Huang X., Chen H., Miller W. C., Lower Low density lipid cholesterol levels are associated with Parkinson's disease. Movement Disorders 2007 22 3 377 381 10.1002/mds.21290 (Pubitemid 46569693)
38. de Lau L. M. L., Koudstaal P. J., Hofman A., Breteler M. M. B., Serum cholesterol levels and the risk of Parkinson's disease. American Journal of Epidemiology 2006 164 10 998 1002 2-s2.0-33750897740 10.1093/aje/kwj283 (Pubitemid 44729842)
39. Simon K. C., Chen H., Schwarzschild M., Ascherio A., Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology 2007 69 17 1688 1695 2-s2.0-36048933577 10.1212/01.wnl.0000271883.45010.8a (Pubitemid 350287125)
40. Pena S. D. J., Bastos-Rodrigues L., Pimenta J. R., Bydlowski S. P., DNA tests probe the genomic ancestry of Brazilians. Brazilian Journal of Medical and Biological Research 2009 42 10 870 876 2-s2.0-71049190118 10.1590/S0100- 879X2009005000026
41. Salazar L. A., Hirata M. H., Cavalli S. A., Machado M. O., Hirata R. D. C., Optimized procedure for DNA isolation from fresh and cryopreserved clotted human blood useful in clinical molecular testing. Clinical Chemistry 1998 44 8 I 1748 1750 2-s2.0-0031873791 (Pubitemid 28381222)
42. Hixson J. E., Vernier D. T., Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. Journal of Lipid Research 1990 31 3 545 548 2-s2.0-0025257612 (Pubitemid 20107994)
43. Williams-Gray C. H., Goris A., Saiki M., Foltynie T., Compston D. A. S., Sawcer S. J., Barker R. A., Apolipoprotein e genotype as a risk factor for susceptibility to and dementia in Parkinson's disease. Journal of Neurology 2009 256 3 493 498 2-s2.0-67349207903 10.1007/s00415-009-0119-8
44. Eichner J. E., Dunn S. T., Perveen G., Thompson D. M., Stewart K. E., Stroehla B. C., Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. American Journal of Epidemiology 2002 155 6 487 495 2-s2.0-0037087052 10.1093/aje/155.6.487 (Pubitemid 34208040)
45. Jacquier M., Arango D., Villareal E., Torres O., Serrano M. L., Cruts M., Montañes P., Cano C., Rodriguez M. N., Serneels S., van Broeckhoven C., APOE ε 4 and Alzheimer's disease: positive association in a Colombian clinical series and review of the Latin-American studies. Arquivos de Neuro-Psiquiatria 2001 59 1 11 17 2-s2.0-0035288137 (Pubitemid 33605833)
46. Hawi Z., Sheehan K., Lynch A., Evans I., Lowe N., Lawlor B., Gill M., Late onset Alzheimer's disease and apolipoprotein association in the Irish population: relative risk and attributable fraction. Irish Journal of Medical Science 2003 172 2 74 76 2-s2.0-0041520971 (Pubitemid 36987419)
47. Monastero R., Mariani E., Camarda C., Ingegni T., Averna M. R., Senin U., Camarda R., Mecocci P., Association between apolipoprotein E ε 4 allele and apathy in probable Alzheimer's disease. Acta Psychiatrica Scandinavica 2006 113 1 59 63 2-s2.0-33644755923 10.1111/j.1600-0447.2005.00597.x (Pubitemid 43339091)
48. Ferreira C. N., Carvalho M. G., Fernandes A. P. S. M., Lima L. M., Loures-Valle A. A., Dantas J., Janka Z., Palotás A., Sousa M. O., Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders. Neurochemistry International 2010 56 1 177 182 2-s2.0-73649146520 10.1016/j.neuint.2009.09.016
49. Sociedade Brasileira de Cardiologia, IV diretriz brasileira sobre dislipidemias e prevenção da aterosclerose. Arquivos Brasileiros de Cardiologia 2007 88 supplement 1
50. Ettinger W. H. Jr., Harris T., Causes of hypocholesterolemia. Coronary Artery Disease 1993 4 10 854 859 2-s2.0-0027372283 (Pubitemid 23350191)
51. Iribarren C., Reed D. M., Chen R., Yano K., Dwyer J. H., Low serum cholesterol and mortality: which is the cause and which is the effect? Circulation 1995 92 9 2396 2403 2-s2.0-0028882612
52. Ettinger W. H. Jr., Harris T., Verdery R. B., Tracy R., Kouba E., Evidence for inflammation as a cause of hypocholesterolemia in older people. Journal of the American Geriatrics Society 1995 43 3 264 266 2-s2.0-0028968729
53. Teunissen C. E., Lütjohann D., Von Bergmann K., Verhey F., Vreeling F., Wauters A., Bosmans E., Bosma H., van Boxtel M. P. J., Maes M., Delanghe J., Blom H. J., Verbeek M. M., Rieckmann P., de Bruijn C., Steinbusch H. W. M., de Vente J., Combination of serum markers related to several mechanisms in Alzheimer's disease. Neurobiology of Aging 2003 24 7 893 902 2-s2.0-0043092171 10.1016/S0197-4580(03)00005-8 (Pubitemid 36962973)
54. Reiss A. B., Siller K. A., Rahman M. M., Chan E. S. L., Ghiso J., de Leon M. J., Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease. Neurobiology of Aging 2004 25 8 977 989 2-s2.0-2942752089 10.1016/j.neurobiolaging.2003.11.009 (Pubitemid 38798059)
55. Musanti R., Parati E., Lamperi E., Ghiselli G., Decreased cholesterol biosynthesis in fibroblasts from patients with Parkinson disease. Biochemical Medicine and Metabolic Biology 1993 49 2 133 142 2-s2.0-0027212432 10.1006/bmmb.1993.1016 (Pubitemid 23197786)
56. Abbott R. D., Ross G. W., White L. R., Nelson J. S., Masaki K. H., Tanner C. M., Curb J. D., Blanchette P. L., Popper J. S., Petrovitch H., Midlife adiposity and the future risk of Parkinson's disease. Neurology 2002 59 7 1051 1057 2-s2.0-0037044236
57. Abbott R. D., Ross G. W., White L. R., Sanderson W. T., Burchfiel C. M., Kashon M., Sharp D. S., Masaki K. H., Curb J. D., Petrovitch H., Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study. Journal of Neurology 2003 250 supplement 3 iii30 iii39 2-s2.0-10744227681
58. de Lau L. M. L., Bornebroek M., Witteman J. C. M., Hofman A., Koudstaal P. J., Breteler M. M. B., Dietary fatty acids and the risk of Parkinson disease: The Rotterdam Study. Neurology 2005 64 12 2040 2045 2-s2.0-21144438922 10.1212/01.WNL.0000166038.67153.9F (Pubitemid 40880989)